All News

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The phase 4 ANNEXA-I trial was stopped early after showing superior hemostatic efficacy and the capability to limit potentially life-threatening intracerebral hemorrhage (ICH) compared with usual care in patients taking oral factor Xa (FXa) inhibitors.

While clinical trials offer controlled data, real-world studies like HEM-POWR bridge gaps, confirming damoctocog alfa pegol’s effectiveness and tolerance, establishing it as a valuable hemophilia A treatment option.

New phase 1B data support further investigation into Adiso Therapeutic's prospective treatment.

Results from the AiDAPT trial show hybrid closed-loop therapy significantly improves maternal glycemic control during pregnancy complicated by T1D.

Half of the surveyed adults reported difficulty affording their health care, and a large proportion said they delayed or avoided care or medication because they couldn’t afford it, often leading to their health problems worsening.

This study aimed to evaluate the association between the disease burden of psoriasis and the switching of systemic biologic therapies in patients with both psoriasis and psoriatic arthritis.

Researchers identified an optimal early relapse time point to incorporate into traditional risk features and formed a novel prognostic classification utilizing both static and dynamic risk.

Posters presented at the American College of Gastroenterology's (ACG's) 2023 Annual Scientific Meeting examined potential environmental risks of eosinophilic esophagitis (EoE) on the pediatric population, as well as the presence of allergic comorbidities in children diagnosed with EoE.

Paroxysmal nocturnal hemoglobinuria (PNH) could be effectively treated by using eculizumab, which was found to be safe in patients.

The Biden administration requested $1.55 billion from Congress to help address the nationwide fentanyl crisis; the US Department of Agriculture reported that millions more Americans were food insecure in 2022; the Biden administration released an updated cybersecurity toolkit to help defend the US health care infrastructure against hackers.

A growing availability of treatment options for digital therapeutics (DTx) requires expanding access and coverage, according to payers in the United States.

The improvement in quality of life (QOL) seen with use of sacubitril/valsartan for heart failure with preserved ejection fraction (HFpEF) could potentially result in more favorable clinical results.

While Black people are consistently underrepresented, White people are consistently overrepresented in inflammatory arthritis trials for rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, and juvenile idiopathic arthritis.

This comprehensive comparative analysis examined the economic and health care resource utilization implications of initiating glucocorticoid and exon-skipping therapy for Duchenne muscular dystrophy (DMD).

A pair of studies found the common morning ritual of hitting the snooze button doesn't dilute the quality of sleep and can improve cognitive function after awakening.

Results from a retrospective, matched cohort study suggested that valvular heart disease and aortic stenosis may contribute to disparities in cardiovascular disease–related mortality in patients with rheumatoid arthritis (RA).

Interviews highlight the importance of culturally-tailored diabetes education to address health care disparities in the Mexican American community.

Patients living with HIV had an interest in future use of telehealth due to high satisfaction in the care provided.

Senators advocate for TRICARE to stock and cover the OTC birth control pill; double the amount of health care workers experienced workplace harassment in 2022 compared with 2018; a survey found that young adults in the United States experienced depression and anxiety twice as often as teenagers.

It is critical to understand the role race and ethnicity play in survival for patients with early-stage breast cancer (eBC), as well as explore potential interventions to close these gaps.

Biases in care for young adults with sickle cell disease could lead to lower quality of care for these patients.

The study indicated the potential of preventative drug lists (PDLs) as a strategy for those who have high deductible health plans to address both patient access and affordability of asthma care.

Eric Donnenfeld, MD, of Ophthalmic Consultants of Long Island, spoke with AJMC about the safety and accessibility of lotilaner ophthalmic solution for patients with Demodex blepharitis.

The location of integration of a gene therapy has been crucial for the safety and efficacy of the treatment to cure infants with X-linked severe combined immunodeficiency.

The incidence of colorectal serrated lesions could be attributed to metabolic syndrome, which causes metabolic dysregulation.

Researchers identified distinct patterns of epigenetic dysregulation in myeloproliferative neoplasms.

The ranibizumab biosimilar was the first in ophthalmology to the US market in 2022, but its competition has already had a year of interchangeability exclusivity.